According to a study in the Archives of General Psychiatry, approximately 90% of patients with MCI and pathologic CSF biomarker levels at baseline develop AD within 9 to 10 years. Levels of Aβ42 are already fully decreased at least 5 to 10 years before conversion to AD dementia, whereas T-tau and P-tau seem to be later markers. [More…]
- Activities▼
- Education Hubs▼
-
- Alzheimer’s Disease
- Cardiology
- COVID-19
- Dermatology
- Diversity & Inclusion
- Gastroenterology
- Hematology
- Immunodeficiency Disorders
- Infectious Disease
- Liver Disease
- Migraine
- Multiple Sclerosis
- Neuropsychiatric
- Oncology
- Ophthalmology
- Pain Management
- Pediatrics
- Pharmacist Central
- Psoriatic Arthritis
- Rare Diseases
- Respiratory
- Rheumatology
- Sleep Disorders
- Virtual Education
-
- Services▼
- News▼
- ▼